Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks in news: TCS, Groww, Shriram Finance, Dixon Tech, Anand Rathi Wealth
Indian markets saw a rebound on Thursday, recovering from Wednesday's sharp sell-off. TCS reported a 5% year-on-year profit growth, and Groww affirmed its direct mutual fund strategy. Shriram Finance is raising funds to reduce borrowing costs after a rating upgrade. Maruti Suzuki plans to add service points, and Dixon Tech will expand smartphone manufacturing. Premier Energies commissioned a solar module facility, and Anand Rathi Wealth saw profit rise.
Vatika Hotels refinance Rs 550 crore debt with Kotak
Vatika Hotels has refinanced Rs 550 crore debt with Kotak Mahindra Bank. This move marks the exit of India Special Assets Fund III from the company. The hotel owner experienced financial stress during the Covid-19 pandemic. Vatika Hotels' debt has significantly declined after restructuring and equity infusion. The company now holds a BBB investment-grade rating, reflecting improved financial health.
M&M Financial shares gain on strong Q1 disbursements but bears flag some key risks on the horizon
Jefferies retained a cautious stance on M&M Financial, citing a subdued growth outlook and potential monsoon-related asset quality risks despite what it described as "reasonable valuations."
NCLAT upholds full PF, gratuity payments for Jet Airways employees
In a landmark decision, the NCLAT has ruled that former Jet Airways employees are entitled to their full provident fund and gratuity dues, even if separate accounts weren't maintained. Financial creditors' appeals were dismissed, affirming these statutory dues must be paid outside the liquidation estate. While salary claims will follow the IBC's waterfall, this ruling offers significant relief to workers.
Nifty has more room to run; stay selective: Analysts
Indian stock markets are showing cautious optimism, with the Nifty eyeing the 24,300-25,000 zone amid ongoing volatility. Analysts recommend selective trading and specific strategies like a moderately bullish Call Spread. Top stock picks include TVS Motor, Samvardhana Motherson International, Oberoi Realty, Aurobindo Pharma, Vijaya Diagnostic Centre, and Mahindra & Mahindra Financial Services, each presenting unique buying opportunities with defined targets and stop losses.
Laurus Labs, Biocon, Ather Energy, Lenskart among probable MSCI India Standard Index inclusion candidates, says JM Financial
JM Financial anticipates significant shifts in the MSCI India Standard Index. Laurus Labs and Biocon are flagged as high-probability additions from the Small Cap Index, while Ather Energy and SAIL are medium-probability candidates. SBI Card faces a high probability of exclusion. These potential changes could lead to substantial passive fund inflows into India, estimated around $3.2 billion, impacting institutional investors.
Buy or sell: Gift Nifty trades flat, Vaishali Parekh recommends three stocks to buy today
Buy or sell: Vaishali Parekh recommends three stocks to buy today — Hero MotoCorp, Pine Labs, and M&M Financial Services
Why top fund managers think foreign investors could return to India
India's market outlook is improving as oil prices ease and geopolitical risks recede. Sunil Singhania, Founder of Abakkus Asset Manager, Prashant Khemka, Founder, Whiteoak Capital and Nilesh Shah, Managing Director at Kotak Mahindra AMC explain why foreign investor sentiment could improve, where earnings growth is strongest, and which sectors—from banks to renewables—offer the most compelling opportunities.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
Ola Electric QIP Fetches Rs 780 Crore As EV Maker's Issue Gets 56% Oversubscription
Mirae Asset received the highest allocation of 15.38% through multiple allocations followed by Motilal Oswal which received 9.61%.